[Google Scholar] 216.US Congress
If you are on a GLP-1 medication , working with a healthcare provider to monitor body composition and nutritional intake can help optimize results and preserve muscle mass
Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis
The body already possesses an extraordinarily sophisticated metabolic control system one that evolved in response to whole foods, complex fibres and a diverse gut microbiome
served as a consultant for Eli Lilly, Novo Nordisk, Sanofi, AstraZeneca, Mundipharma
Having cleared the hurdle as a treatment for diabetes, the FDA then approved semaglutide, marketed as Wegovy, for obesity in 2021, and then in Europe the following year